Get 25% discount on our yearly plans! Subscribe now

NVTA by TradingView
Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets 535.12M
Total Liability 1.62B
Assets-to-Libability Ratio 0.33
Total Current Assets 378.40M
Total Current Liability 158.42M
Current Ratio 2.39
Quick Ratio 2.25
Debt to Equity Ratio -1.27
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News

Profile

Invitae Corp (NVTA)

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.

Exchange: NYSE

IPO Date: 2/12/2015

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 1700

Address: 1400 16th Street, San Francisco, CA, United States, 94103

https://www.invitae.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;09/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/202109/30/202106/30/2021Totals
Assets
535.12K1.52M1.69M1.95M2.03M2.29M4.77M4.92M5.07M5.00M45.47M
Current Assets
378.40K451.23K504.27K693.13K729.68K894.25K1.03M1.18M1.37M1.64M15.03M
Cash And Short Term Investments
254.57K325.14K378.70K547.10K585.97K726.76K874.71K1.05M1.24M1.53M12.69M
Net Receivables
82.51K85.61K85.59K96.15K89.13K82.59K80.40K66.23K58.43K55.71K1.20M
Inventory
21.63K20.81K19.07K30.39K29.90K49.07K43.46K33.52K30.63K29.98K431.36K
Other Current Assets
19.69K19.66K20.91K19.50K24.68K35.83K32.04K33.69K34.40K28.09K604.94K
Non Current Assets
156.72K1.07M1.19M1.26M1.30M1.40M3.74M3.74M3.71M3.35M30.45M
Property Plant Equipment
-92.09K95.44K-113.88K132.94K129.96K235.88K220.19K203.60K2.03M
Long Term Investments
----------41.88K
Non Currrent Assets Other
29.63K31.08K32.01K33.15K31.55K37.55K38.97K33.83K34.06K29.58K564.40K
Liabilities
1.62M1.72M1.73M1.85M1.87M1.90M1.92M1.94M1.96M2.34M25.54M
Current Liabilities
158.42K151.97K190.18K108.09K113.32K139.25K167.90K144.09K156.17K133.64K2.67M
Accounts Payable
25.18K23.07K11.90K13.98K10.73K26.75K41.70K21.13K35.40K31.24K1.14M
Short Long Term Debt
26.91K-71.90K-------331.20K
Other Current Liabilities
79.94K102.71K79.41K69.57K77.45K88.60K101.53K-1.40K96.05K82.49K1.23M
Non Current Liabilities
1.46M1.57M1.54M1.74M1.75M1.77M1.76M1.80M1.81M2.21M22.87M
Long Term Debt
-1.17M1.17M-1.59M1.59M1.58M1.58M1.57M1.57M14.63M
Other Liabilities
----21.85K31.26K-89.49K107.56K741.40K2.99M
Stockholder Equity
-1.08M-200.79K-36.66K101.84K158.87K385.90K2.84M2.98M3.11M2.65M20.14M
Preferred Stock Equity
----------336.21K
Liabilities And Stockholders Equity
535.12K1.52M1.69M1.95M2.03M2.29M4.77M4.92M5.07M5.00M45.47M
Common Equity
-2726-242423232320380
Retained Earnings
--5.23M-5.02M--4.73M-4.43M-1.90M-1.72M-1.52M-1.32M-39.07M
Totals4.30M4.46M5.44M10.48M7.82M9.44M22.01M23.03M24.16M25.31M17.81M15.74M4.04M4.36M3.62M3.63M3.77M2.01M1.99M1.08M1.07M869.52K825.36K818.47K884.55K543.36K601.17K447.75K328.21K443.79K547.86K647.69K757.62K872.42K1.02M1.16M455.14K--206.79M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/2014Totals
Assets
1.95M4.92M3.42M781.60K282.96K211.08K130.65K156.68K128.78K11.99M
Current Assets
693.13K1.18M453.93K442.40K165.44K86.68K101.80K131.31K109.64K3.36M
Cash And Short Term Investments
547.10K1.05M353.98K391.82K125.89K64.66K92.62K127.02K-2.75M
Net Receivables
96.15K66.23K47.72K32.54K26.30K10.42K1.15K--280.51K
Inventory
30.39K33.52K32.03K6.60K8.30K5.40K---116.23K
Other Current Assets
19.50K33.69K20.20K18.03K13.26K11.60K9.18K4.29K2.62K132.36K
Non Current Assets
1.26M3.74M2.97M339.20K117.52K124.40K28.85K25.37K19.14K8.63M
Property Plant Equipment
-235.88K66.10K37.75K27.89K30.34K23.79K18.71K15.67K456.13K
Long Term Investments
-----5.98K---5.98K
Non Currrent Assets Other
33.15K33.83K19.87K12.86K9.07K5.98K5.06K6.66K3.46K129.94K
Liabilities
1.85M1.94M1.45M401.96K121.12K89.28K31.58K18.30K212.35K6.12M
Current Liabilities
108.09K144.09K121.75K81.86K36.31K33.39K14.75K10.88K7.62K558.75K
Accounts Payable
13.98K21.13K25.20K10.32K7.81K8.61K10.06K7.75K2.86K107.73K
Short Long Term Debt
-----44.50K3.38K1.54K3.54K52.95K
Other Current Liabilities
69.57K97.02K79.68K63.38K27.74K24.78K1.68K4.25K3.24K371.35K
Non Current Liabilities
1.74M1.80M1.33M320.10K84.81K55.90K16.82K7.42K204.73K5.56M
Long Term Debt
-1.58M388.17K268.75K75.85K42.46K8.99K7.08K-2.37M
Other Liabilities
-89.49K892.79K8.00K8.96K13.44K7.84K3434151.02M
Stockholder Equity
101.84K2.98M1.97M379.64K161.84K121.79K99.07K138.38K118.73K6.07M
Preferred Stock Equity
--------202.31K202.31K
Liabilities And Stockholders Equity
1.95M4.92M3.42M781.60K282.96K211.08K130.65K156.68K128.78K11.99M
Common Equity
-2319108544-73
Retained Earnings
--1.72M-1.36M-758.68K-516.71K-398.60K-275.22K-174.96K--5.21M
Totals10.48M23.13M15.71M3.62M1.07M803.17K442.72K647.69K1.16M57.07M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;06/30/202203/31/202212/31/202109/30/202106/30/202103/31/202112/31/202009/30/202006/30/202003/31/2020Totals
Revenue
136.62K123.69K126.12K114.39K116.31K103.62K100.43K68.73K46.19K64.25K1.47M
Cost Of Revenue
110.34K97.12K96.11K87.74K89.33K75.49K68.26K46.64K42.95K40.42K1.05M
Gross Profit
26.28K26.57K30.02K26.65K26.98K28.13K32.17K22.09K3.24K23.83K415.36K
Operating Expenses
2.55M239.65K340.69K239.83K201.72K140.49K363.66K102.91K145.32K121.61K5.34M
Selling General Administrative
113.60K51.27K50.43K86.82K38.30K8.90K242.61K27.31K30.84K23.82K896.47K
Research Development
115.15K128.24K131.76K97.51K106.45K80.36K72.17K37.80K74.96K55.67K1.26M
Other Operating Expenses
-336.77K340.69K327.57K291.05K215.99K431.91K149.55K188.27K162.03K3.64M
Operating Income
-2.52M-213.23K-214.57K-193.31K128.61K-112.36K-331.48K-80.82K-142.08K-97.78K-4.50M
Net Interest Income
-14.02K-13.98K-14.03K-14.07K-13.41K-8.39K-12.52K-6.31K-5.49K-5.45K-120.08K
Interest Income
----------5.45K-17.86K
Interest Expense
14.02K13.98K-14.03K14.07K13.41K8.39K12.52K6.31K5.49K5.45K103.47K
Other Income Expense Net
-2.31M-3.55K1.80K-10.71K-11.38K-3.93K-12.36K22.08K26.92K743-2.27M
Income Before Tax
-2.53M-216.78K-212.77K-204.02K117.23K-116.29K-343.84K-102.90K-169.00K-98.53K-4.63M
Tax Provision
-3.56K-34.92K-7.65K-5.85K-16.56K-6.80K-102.80K--2.60K--199.19K
NetIncome
-2.52M-181.86K-205.12K-198.18K133.79K-109.49K-234.34K-102.90K-166.40K-98.53K-4.42M
NetIncome Applicable To Common Shares
-2.52M-181.86K-205.12K-198.18K-128.97K-109.49K-234.34K-102.90K-166.40K-98.53K-4.68M
Ebit
-2.51M-202.79K-226.80K-189.96K130.63K-107.90K-331.32K-80.82K-163.52K-97.78K-4.52M
Basic EPS
--0.78-0.81-0.91-0.85-0.63-0.63-0.62-0.77-0.8-36.84
Totals-11.87M-31.67K17.52K-19.68K1.22M86.71K-279.26K6.75K-251.31K-4.23K60.12K9.09K78.54K58.60K103.08K66.75K65.38K12.33K-2.74K-2.79K-17.72K-32.77K-27.69K-39.73K-41.48K-50.34K-50.06K-47.39K-53.30K-42.24K-65.99K-16.75K-12.71K-11.31K-11.18M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/2014Totals
Revenue
460.45K279.60K216.82K147.70K68.22K25.05K8.38K1.60K1.21M
Cost Of Revenue
348.67K198.28K118.10K80.11K50.14K27.88K16.52K5.62K845.32K
Gross Profit
111.78K81.32K98.72K67.59K18.08K-2.83K-8.14K-4.02K362.50K
Operating Expenses
890.07K733.50K342.83K190.15K139.36K97.35K81.33K43.33K2.52M
Selling General Administrative
248.07K324.57K79.07K52.23K39.47K24.09K16.05K12.60K796.14K
Research Development
416.09K240.60K141.53K63.50K46.47K44.63K42.81K22.06K1.02M
Other Operating Expenses
852.09K931.77K460.94K270.26K189.50K125.23K97.86K48.96K2.98M
Operating Income
-391.64K-652.17K-244.11K-122.56K-121.28K-100.18K-89.48K-47.35K-1.77M
Net Interest Income
-49.90K-29.77K-12.41K-7.03K-3.65K-421---103.18K
Interest Income
---12.41K-7.03K-3.65K-421-211--23.73K
Interest Expense
-49.90K29.77K12.41K7.03K3.65K421211613.65K
Other Income Expense Net
-24.22K-62.10K-16.30K-9.60K3.96K73305140-107.75K
Income Before Tax
-415.86K-714.27K-260.42K-132.16K-125.24K-100.26K-89.78K-47.49K-1.89M
Tax Provision
-36.86K-105.40K-18.45K-2.80K-1.86K----165.36K
NetIncome
-379.01K-602.17K-241.97K-129.35K-123.38K-100.26K-89.78K-47.49K-1.71M
NetIncome Applicable To Common Shares
-379.01K-602.17K-241.97K-129.35K-123.38K-100.26K-89.78K-47.49K-1.71M
Ebit
-465.76K-684.50K-248.00K-125.13K-121.58K-100.18K-89.48K-47.35K-1.88M
Basic EPS
-3.2-2.82-2.31-1.98-2.65-3.03-3.32-16.75-36.06
Totals1.14M-633.15K174.39K213.55K-65.17K-160.09K-193.20K-106.84K364.54K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;09/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/202109/30/202106/30/2021Totals
Cash From Operating Activities
-66.89K-54.91K-34.40K-82.03K-128.70K-134.69K-147.54K-175.92K-165.05K-129.32K-2.04M
Net Income
-942.11K-206.51K-192.18K-99.82K-301.16K-2.52M-181.86K-205.12K-198.18K133.79K-6.16M
Depreciation
31.74K33.70K34.96K37.34K40.48K37.15K27.10K23.62K21.59K18.69K415.11K
Extraordinary Items
-----------
Change Receivables
--1810.56K--6.54K-2.19K-14.17K-7.80K-1.95K-9.77K-45.26K
Change To Inventory
-813-1.74K11.32K-48419.17K-5.62K-9.94K-2.88K-651674-20.93K
Change To Liabilities
-24.77K6.62K--20.65K-7.93K21.69K-11.84K-1.20K-6.45K77.61K
Change To Net Income
-89.66K71.93K-111.66K2.37M13.71K30.37K3.26K-10.48K3.01M
ChangeToOperatingActivities
----8.26K4.45K4.45K-6.14K8.22K2.73K57.32K
Cash flows From Investing Activities
-116.06K73.88K-43.80K108.97K-449.46K170.50K-20.32K-80.70K-1.05M
Capital Expenditures
-1.93K-1.42K-1.32K-4.92K-11.41K-16.12K-20.85K-19.19K-15.38K-13.72K-193.03K
Other Cashflows From Investing Activities
-335------7.56K580-900-463.51K
Cash From Financing Activities
-3.38K876-135.77K599-1.69K3.77K-9207.03K-7351.12M3.08M
Net Borrowings
---133.01K--1.51K-1.35K-1.35K-926-3.26K1.12M2.51M
Sale Purchase Of Stock
-2.17K1-335.81K4257.96K4.09K9.17K575.86K
Dividends Paid
-----------
Other Cashflows From Financing Activities
-2.07K-6520-65-9.88K-692-15170.50K-2.00K1.11M2.03M
Cash And Cash Equivalents Changes
-62.03K-96.29K--86.60K-21.95K-597.92K1.62K-186.11K913.53K81.08K
Totals-985.45K65.01K-383.20K-149.37K-344.73K-180.55K-1.36M-25.77K-557.09K4.18M1.22M88.74K-207.63K28.98K-228.06K-722.22K973.93K-14.44K219.32K95.18K91.39K36.55K15.31K-66.24K21.46K-50.56K-2.22K141.44K1.11K-8.89K-114.83K24.00K-15.47K-65.64K10.94K95.16K72.44K-21.70K-17.77K1.86M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/2014Totals
Cash From Operating Activities
-238.22K-492.96K-559.82K-299.35K-145.05K-92.22K-97.98K-76.32K-80.66K-42.44K-2.13M
Net Income
-1.44M-3.11M-379.01K-608.87K-241.97K-129.35K-123.38K-100.26K-89.78K-47.49K-6.27M
Depreciation
137.75K142.07K80.47K39.05K16.21K13.54K9.18K6.55K5.32K2.31K452.46K
Extraordinary Items
-----------
Change Receivables
---16.70K-2.81K-6.13K-5.29K-1.96K----32.90K
Change To Inventory
8.28K3.13K-1.49K-7.83K11.32K-2.85K-2.85K---7.71K
Change To Liabilities
---9.26K27.73K17.86K3.15K-5725.87K1.31K2.07K48.16K
Change To Net Income
---247.89K160.17K48.98K26.98K17.63K11.73K3.50K1.01K22.12K
ChangeToOperatingActivities
---17716.43K13.34K1.96K-8636.30K-525-34336.12K
Cash flows From Investing Activities
---204.08K-400.58K-280.31K35.77K-36.95K16.20K-65.57K-6.72K-942.25K
Capital Expenditures
-9.59K-53.31K-54.72K-22.86K-20.05K-5.97K-6.67K-11.63K-6.46K-6.69K-197.95K
Other Cashflows From Investing Activities
---1.30K-387.78K-33.85K-1.00K2.82K134-4.68K-30-425.68K
Cash From Financing Activities
-137.67K1.76K1.57M673.84K464.77K157.15K80.87K53.71K112.44K113.11K3.09M
Net Borrowings
--1.11M129.21K254.26K27.20K6.25K3.47K-2.42K-1.38K1.53M
Sale Purchase Of Stock
--23.77K284.20K9.47K17.51K74.62K50.24K107.41K209567.42K
Dividends Paid
-----------
Other Cashflows From Financing Activities
--10.65K1.11M130.95K328.35K89.30K39.66K10.63K7.74K114.49K1.82M
Cash And Cash Equivalents Changes
--802.04K-26.09K39.41K100.70K-54.06K-6.41K-33.79K-821.80K
Totals-1.68M-3.52M3.22M-294.59K476.62K236.59K-94.26K-29.77K-46.17K128.12K-1.60M